Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.

Author
:
D Cornec
BF Kabat
Mills JR
M Cheu
AM Hummel
DR Schroeder
MD Cascino
P Brunetta
DL Murray
MR Snyder
F Fervenza
GS Hoffman
CGM Kallenberg
CA Langford
PA Merkel
PA Monach
P Seo
RF Spiera
EW St Clair
JH Stone
DR Barnidge
U Specks
Abstract
:

To study the determinants of the pharmacokinetics (PK) of rituximab (RTX) in patients with ANCA-associated vasculitis (AAV) and its association with clinical outcomes.
Year of Publication
:
2018
Journal
:
Rheumatology (Oxford, England)
Date Published
:
2018
ISSN Number
:
1462-0324
URL
:
https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/kex484
DOI
:
10.1093/rheumatology/kex484
Short Title
:
Rheumatology (Oxford)
Download citation